Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Related structures:
AlphaFold database: A4HPX1
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 18 |
GO:0006793 | phosphorus metabolic process | 3 | 18 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 18 |
GO:0006807 | nitrogen compound metabolic process | 2 | 18 |
GO:0008152 | metabolic process | 1 | 18 |
GO:0009987 | cellular process | 1 | 18 |
GO:0016310 | phosphorylation | 5 | 18 |
GO:0019538 | protein metabolic process | 3 | 18 |
GO:0036211 | protein modification process | 4 | 18 |
GO:0043170 | macromolecule metabolic process | 3 | 18 |
GO:0043412 | macromolecule modification | 4 | 18 |
GO:0044237 | cellular metabolic process | 2 | 18 |
GO:0044238 | primary metabolic process | 2 | 18 |
GO:0071704 | organic substance metabolic process | 2 | 18 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 18 |
GO:0003676 | nucleic acid binding | 3 | 6 |
GO:0003746 | translation elongation factor activity | 4 | 6 |
GO:0003824 | catalytic activity | 1 | 18 |
GO:0004672 | protein kinase activity | 3 | 18 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 18 |
GO:0005488 | binding | 1 | 18 |
GO:0005524 | ATP binding | 5 | 18 |
GO:0008135 | translation factor activity, RNA binding | 3 | 6 |
GO:0016301 | kinase activity | 4 | 18 |
GO:0016740 | transferase activity | 2 | 18 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 18 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 18 |
GO:0017076 | purine nucleotide binding | 4 | 18 |
GO:0030554 | adenyl nucleotide binding | 5 | 18 |
GO:0032553 | ribonucleotide binding | 3 | 18 |
GO:0032555 | purine ribonucleotide binding | 4 | 18 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 18 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 18 |
GO:0036094 | small molecule binding | 2 | 18 |
GO:0043167 | ion binding | 2 | 18 |
GO:0043168 | anion binding | 3 | 18 |
GO:0045182 | translation regulator activity | 1 | 6 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 6 |
GO:0097159 | organic cyclic compound binding | 2 | 18 |
GO:0097367 | carbohydrate derivative binding | 2 | 18 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 18 |
GO:1901265 | nucleoside phosphate binding | 3 | 18 |
GO:1901363 | heterocyclic compound binding | 2 | 18 |
GO:0004683 | calmodulin-dependent protein kinase activity | 5 | 5 |
GO:0016905 | myosin heavy chain kinase activity | 6 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 162 | 164 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 205 | 207 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 214 | 216 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 162 | 164 | PF00082 | 0.445 |
CLV_PCSK_PC1ET2_1 | 205 | 207 | PF00082 | 0.369 |
CLV_PCSK_PC1ET2_1 | 214 | 216 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 137 | 141 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 295 | 299 | PF00082 | 0.508 |
DEG_APCC_DBOX_1 | 136 | 144 | PF00400 | 0.219 |
DOC_CYCLIN_RxL_1 | 159 | 168 | PF00134 | 0.197 |
DOC_MAPK_gen_1 | 213 | 222 | PF00069 | 0.450 |
DOC_PP1_RVXF_1 | 160 | 167 | PF00149 | 0.197 |
DOC_PP1_RVXF_1 | 73 | 79 | PF00149 | 0.392 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.503 |
DOC_USP7_UBL2_3 | 201 | 205 | PF12436 | 0.181 |
DOC_USP7_UBL2_3 | 291 | 295 | PF12436 | 0.529 |
DOC_WW_Pin1_4 | 15 | 20 | PF00397 | 0.678 |
LIG_14-3-3_CanoR_1 | 137 | 143 | PF00244 | 0.303 |
LIG_14-3-3_CanoR_1 | 170 | 178 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 67 | 76 | PF00244 | 0.459 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.437 |
LIG_BIR_III_1 | 1 | 5 | PF00653 | 0.437 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.437 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.450 |
LIG_Clathr_ClatBox_1 | 178 | 182 | PF01394 | 0.334 |
LIG_Clathr_ClatBox_1 | 219 | 223 | PF01394 | 0.492 |
LIG_CSL_BTD_1 | 16 | 19 | PF09270 | 0.438 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.420 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.500 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.425 |
LIG_FHA_2 | 227 | 233 | PF00498 | 0.324 |
LIG_FHA_2 | 302 | 308 | PF00498 | 0.395 |
LIG_LIR_Gen_1 | 124 | 132 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 223 | 231 | PF02991 | 0.309 |
LIG_LIR_Gen_1 | 311 | 320 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 193 | 199 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 223 | 228 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 311 | 316 | PF02991 | 0.567 |
LIG_MLH1_MIPbox_1 | 106 | 110 | PF16413 | 0.392 |
LIG_NRBOX | 352 | 358 | PF00104 | 0.435 |
LIG_REV1ctd_RIR_1 | 164 | 174 | PF16727 | 0.308 |
LIG_SH2_CRK | 313 | 317 | PF00017 | 0.424 |
LIG_SH2_GRB2like | 109 | 112 | PF00017 | 0.401 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.259 |
LIG_SH2_STAP1 | 349 | 353 | PF00017 | 0.603 |
LIG_SH2_STAP1 | 46 | 50 | PF00017 | 0.285 |
LIG_SH2_STAT3 | 349 | 352 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.359 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.380 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.436 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.322 |
LIG_SH3_4 | 291 | 298 | PF00018 | 0.342 |
LIG_TRAF2_1 | 208 | 211 | PF00917 | 0.392 |
LIG_TRAF2_1 | 342 | 345 | PF00917 | 0.459 |
LIG_TRAF2_1 | 79 | 82 | PF00917 | 0.259 |
LIG_TRAF2_2 | 325 | 330 | PF00917 | 0.388 |
LIG_UBA3_1 | 331 | 336 | PF00899 | 0.451 |
LIG_WRC_WIRS_1 | 139 | 144 | PF05994 | 0.284 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.311 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.295 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.295 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.560 |
MOD_CK1_1 | 339 | 345 | PF00069 | 0.494 |
MOD_CK1_1 | 70 | 76 | PF00069 | 0.262 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.509 |
MOD_CK2_1 | 205 | 211 | PF00069 | 0.413 |
MOD_CK2_1 | 226 | 232 | PF00069 | 0.344 |
MOD_CK2_1 | 301 | 307 | PF00069 | 0.461 |
MOD_CK2_1 | 339 | 345 | PF00069 | 0.499 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.306 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.278 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.344 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.479 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.591 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.270 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.281 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.307 |
MOD_GSK3_1 | 301 | 308 | PF00069 | 0.406 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.548 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.441 |
MOD_GSK3_1 | 351 | 358 | PF00069 | 0.355 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.469 |
MOD_N-GLC_1 | 187 | 192 | PF02516 | 0.401 |
MOD_N-GLC_1 | 305 | 310 | PF02516 | 0.441 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.381 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.295 |
MOD_NEK2_1 | 293 | 298 | PF00069 | 0.354 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.562 |
MOD_NEK2_1 | 351 | 356 | PF00069 | 0.550 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.433 |
MOD_PIKK_1 | 319 | 325 | PF00454 | 0.560 |
MOD_PIKK_1 | 67 | 73 | PF00454 | 0.360 |
MOD_PKA_1 | 205 | 211 | PF00069 | 0.259 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.425 |
MOD_PKA_2 | 205 | 211 | PF00069 | 0.259 |
MOD_PKA_2 | 301 | 307 | PF00069 | 0.554 |
MOD_PKA_2 | 308 | 314 | PF00069 | 0.571 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.239 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.392 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.308 |
MOD_Plk_4 | 308 | 314 | PF00069 | 0.433 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.451 |
MOD_ProDKin_1 | 15 | 21 | PF00069 | 0.681 |
MOD_SUMO_rev_2 | 257 | 262 | PF00179 | 0.362 |
TRG_DiLeu_BaEn_1 | 34 | 39 | PF01217 | 0.349 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.466 |
TRG_ER_diArg_1 | 215 | 218 | PF00400 | 0.360 |
TRG_NLS_MonoExtN_4 | 213 | 218 | PF00514 | 0.351 |
TRG_Pf-PMV_PEXEL_1 | 336 | 340 | PF00026 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1L4 | Leptomonas seymouri | 53% | 100% |
A0A0S4IVQ7 | Bodo saltans | 33% | 82% |
A0A0S4J072 | Bodo saltans | 52% | 84% |
A0A1X0NJ27 | Trypanosomatidae | 46% | 100% |
A0A3Q8IGH4 | Leishmania donovani | 55% | 100% |
A0A3Q8IJS7 | Leishmania donovani | 80% | 97% |
A4HPX3 | Leishmania braziliensis | 58% | 100% |
A4IDN3 | Leishmania infantum | 80% | 97% |
A4IDN5 | Leishmania infantum | 55% | 100% |
C9ZME6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
C9ZWN7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9ATN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 97% |
E9ATN9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 55% | 100% |
Q4Q0U3 | Leishmania major | 54% | 100% |
Q4Q0W0 | Leishmania major | 82% | 100% |
V5AN54 | Trypanosoma cruzi | 49% | 100% |